Carerx Corporation · TSX:CRRX
Carerx — Q3 2022 Earnings Presentation
16 slides from Carerx's earnings presentation, Nov 9, 2022
Slide 1: Q3 2022 Earnings Call
Slide 2: Cautionary Statements
Cautionary Statements Forward Looking Statements Certain of the statements contained in this presentation are "forward looking information within the meaning of applicable Canadian securities legislation. Forward looking information includes, but is not limited to, business strategy, plans and other
Slide 3: David Murphy, President & Chief Executive Officer
David Murphy President & Chief Executive Officer
Slide 4: Continued growth in revenue and Adjusted EBITDA
Q3 2022 Continued growth in revenue and Adjusted EBITDA Contribution from organic growth Signed new long-term agreement with large national customer Announced expansion to Atlantic Canada
Slide 5: Q3 2022 Financial Highlights
Q3 2022 Financial Highlights From Continuing Operations - Average beds serviced of 96,517: +18% vs Q3/21 * Growth driven by: (+/- compared to Q3 2021) (millions) Q3 2022 * Acquisitions completed in 2021 Revenue $97.4 437% * Full quarter contribution from the MPGL LTC Pharmacy Adjusted EBITDA $77 +12
Slide 6: Q3 '19 Q3 '20 Q3 '21 Q3 '22 Q3 '19 Q3 '20 Q3 '21
Q3 '19 Q3 '20 Q3 '21 Q3 '22 Q3 '19 Q3 '20 Q3 '21 Q3 '22 Q3 '19 Q3 '20 Q3 '21 Q3 '22
Slide 7: New Long-Term Agreement with Large National Customer
New Long-Term Agreement with Large National Customer * 5 year extension for over 4,500 beds currently serviced by the Company, including approximately 3,400 beds expected to be acquired by the customer from another existing Customer * Over 1,200 new beds expected to be onboarded as a result of the c
Slide 8: Announced Expansion to Atlantic Canada
Announced Expansion to Atlantic Canada Largest Network in the Sector October 3, 2022: Announced a multi-year contract to provide pharmacy services to residents in multiple seniors living facilities in Atlantic Canada * Establishing pharmacy services operations in Atlantic Canada + Initially serving
Slide 9: Andrew Mok, Chief Financial Officer
Andrew Mok Chief Financial Officer
Slide 10: • • • Q3 2021 Q3 2022
110 • 100 • 90 80 70 60 • 50 40 30 20 10 0 Q3 2021 Q3 2022
Slide 11: • • • • • Q3 2021 Q3 2022
• 10 • 9 • 8 7 • 6 5 4 • 3 2 1 0 Q3 2021 Q3 2022
Slide 12: Q3 2022 Financial Results | Net Loss
Q3 2022 Financial Results | Net Loss ' my Q3 2021 -$3.9 (millions) Q3 2022 -$1.8 * Decrease in net loss to $1.8 million driven primarily by the full quarter contribution of the MPGL LTC Pharmacy business and decreases in other costs, partially offset by the commencement of the offoboarding of a larg
Slide 13: Balance Sheet
Balance Sheet * Increase in cash balance driven primarily by cash provided by operating activities * Timing of working capital reversed negative working capital movement from Q2 2022 (millions except ratio) At September 30/22 Cash $17.9M + Increase in operating cash partially offset by capex and fin
Slide 14: David Murphy, President & Chief Executive Officer
David Murphy President & Chief Executive Officer 14
Slide 15: Continued Long-Term Growth Trajectory
Continued Long-Term Ss CareRx Growth Trajectory >95,000! beds * Continued confidence in organic growth prospects Robust business development pipeline New bed license allocations to existing customers Beds in Canada expected to double in 15 years Market Cpe Minis We) says Organic Growth & Acquisition
Slide 16: Questions
J *.. Questions , Wee Visit our website at www.carerx.ca | Follow @CareRx on Twitter $$ CareRx